S. Nagai

发表

Effectiveness and Safety of Molecular-Targeted Therapy after Nivolumab Plus Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study

Tomoki Taniguchi, Daiki Kato, S. Takeuchi, 2022, Cancers.

immune-checkpoint-inhibitor antibody, following the failure of systemic treatment with chemotherapy and targeted therapy. The patient underwent right radical nephrectomy and segmentectomy of the lung following chemotherapy. Fifteen months following the first surgery, segmentectomy and subsequent sec

T. Miyazaki, T. Deguchi, Kengo Horie, 2017 .

Efficacy and Safety of Cabozantinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study

Tomoki Taniguchi, Daiki Kato, S. Takeuchi, 2022, Biomedicines.

Utility of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune Inflammation Index as Prognostic, Predictive Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab and Ipilimumab

Daiki Kato, Makoto Kawase, Kota Kawase, 2021, Journal of clinical medicine.

Response to nivolumab in metastatic collecting duct carcinoma expressing PD-L1: A case report

T. Miyazaki, T. Deguchi, Kengo Horie, 2017, Molecular and clinical oncology.

The Efficacy and Safety of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor Combination Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Real-World Cohort Study

Tomoki Taniguchi, Daiki Kato, Shota Ueda, 2023, Cancers.

Efficacy and Safety of Nivolumab and Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study

Daiki Kato, Makoto Kawase, Kota Kawase, 2021, Current oncology.

Atypical severe central serous chorioretinopathy in a patient with systemic lupus erythematosus improved with a rapid reduction in glucocorticoid

A. Murasawa, S. Ito, I. Narita, 2013, Modern rheumatology.

Rapid Progression of a Urinary Bladder Leiomyosarcoma: Report of a Case

Toru Yamada, Y. Kanimoto, S. Nagai, 2011, Case reports in urology.

Oncologic Outcomes of Patients with Immune Checkpoint Inhibitor Resistant Urothelial Carcinoma Treated with Enfortumab Vedotin and the Impact of Neutrophil-to-Lymphocyte Ratio and Dysgeusia on Overall Survival: A Retrospective Multicenter Cohort Study in Japan

Tomoki Taniguchi, Makoto Kawase, Kota Kawase, 2024, Cancers.

[Laparoscopic left partial nephrectomy for renal cell carcinoma associated with ITP with platelet count of 10,000/μL].

S. Maeda, Kengo Horie, S. Nagai, 2013, Hinyokika kiyo. Acta urologica Japonica.